Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × In Situ Hybridization, Fluorescence × Clear all

NCT00112827 2025-06-06

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

Phase 1/2 Completed

54 enrolled 13 charts

Smoldering Multiple Myeloma, Multiple Myeloma